Carbohydrate metabolism in pregnancy. XV. Plasma C-peptide during intravenous glucose tolerance in neonates from normal and insulin-treated diabetic mothers. 1978

R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011254 Pregnancy in Diabetics The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy. Pregnancy in Diabetes,Pregnancy in Diabete,Pregnancy in Diabetic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
September 1972, Acta endocrinologica,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
October 1967, Obstetrics and gynecology,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
May 1968, Pediatric research,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
July 1969, Pediatrics,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
October 1967, American journal of obstetrics and gynecology,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
July 1978, Lakartidningen,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
January 1987, Diabetes research and clinical practice,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
July 2001, European journal of endocrinology,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
August 1975, British medical journal,
R L Phelps, and N Freinkel, and A H Rubenstein, and H Kuzuya, and B E Metzger, and J J Boehm, and L Mølsted-Pedersen
August 1979, Nihon Naibunpi Gakkai zasshi,
Copied contents to your clipboard!